Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STOP-AUST: Tranexamic Acid for ICH Growth Prevention
NCT01702636Phase 2Completed
- Sponsor
- Neuroscience Trials Australia
- Start
- Dec 2012
- Primary completion
- Aug 2019
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of tranexamic acid in intracerebral hemorrhage (ICH), sponsored by Neuroscience Trials Australia. Started Dec 2012; status: completed.
02
Drugs
tranexamic acid
03
Conditions
intracerebral hemorrhage (ICH)
Beyond the preview
Go deeper on NCT01702636.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01702636.